Professor, Perelman School of Medicine at the University of Pennsylvania
Radiation Oncology
Dr. Amit Maity, MD
|
|
Give Review
Amit Maity practices Radiation Oncology. He studied medicine at Boston University School of Medicine. Boston University School of Medicine has a rank of 30 in research and a 52 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification". Amit Maity is a published doctor as well. He has 54 publications published. The latest was: Low-dose amiodarone in severe chronic heart failure.
Publications
- The implementation and assessment of a quality and safety culture education program in a large radiation oncology department.
- Factors associated with event reporting in the pediatric radiation oncology population using an electronic incident reporting system.
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
- Awakening the immune system with radiation: Optimal dose and fractionation.
- Galectin-1 and Immune Suppression during Radiotherapy.
- A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme.
- The surgical treatment of atrial myxomas. Clinical experience and results in eight patients.
- Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the rat.
- Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235.
- Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia.
- Radiotherapy and the tumor microenvironment: mutual influence and clinical implications.
- Low-dose amiodarone in severe chronic heart failure.
- Risk stratification by treadmill testing in acute myocardial infarction following thrombolytic therapy.
- Clinical and haemodynamic aspects of hepatopulmonary syndrome in Indian patients with cirrhosis.
- PI3K/AKT/mTOR Pathway in Angiogenesis.
- In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection.
- Location, location, location-makes all the difference for hypoxia in lung tumors.
- The tumor microenvironment in non-small-cell lung cancer.
- Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy.
- Modulating the tumor microenvironment to increase radiation responsiveness.
- Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy.
- Modulating the tumor microenvironment to improve radiotherapy.
- General principles of radiation and chemoradiation.
- Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT.
- M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo.
- Sirolimus as a potential radiosensitizer in squamous cell cancer of the head and neck.
- Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: implications for the mechanism of H...
- Aiding and ABT'ing Treatment for Glioblastoma.
- Childhood intracranial ependymoma: twenty-year experience from a single institution.
- Inhibition of phosphatidylinositol-3-OH kinase/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation.
- Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.
- The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response.
- Cellular responses to EGFR inhibitors and their relevance to cancer therapy.
- Bortezomib sensitizes human head and neck carcinoma cells SQ20B to radiation.
- HIF and MIF--a nifty way to delay senescence?
- The chemokine receptor CXCR4: a homing device for hypoxic cancer cells?
- HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells.
- Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
- 2-Deoxyglucose and radiosensitization: teaching an old DOG new tricks?
- Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway.
- Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis.
- EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.
- Regulation of histone deacetylase 4 expression by the SP family of transcription factors.
- Pulmonary function abnormalities in children treated with whole lung irradiation.
- Effects of hyperbaric oxygen exposure on experimental head and neck tumor growth, oxygenation, and vasculature.
- Treatment of pediatric intracranial arteriovenous malformations with linear-accelerator-based stereotactic radiosurgery: the University of Pennsylvania experience.
- Testicular seminoma 16 years after treatment for CNS germinoma.
- Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.
- Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic ...
- Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years' experience in a single center.
- Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.
- Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
- PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transac...
Schools
Boston Univ Sch Of Med
Mt Sinai Hospital
University Penn Hospital
Doctors Specialties
- Internal Medicine
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania -
University of Pennsylvania Health System -
Mount Sinai School of Medicine -
Boston University School of Medicine
Hospital
-
Philadelphia Veterans Affairs Medical Center -
Hospital of the University of Pennsylvania -
Pennsylvania Hospital -
Penn Presbyterian Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730119728 |
| Last Name Of The Provider | MAITY |
| First Name Of The Provider | AMIT |
| View All |
Similar Doctors
|
|
Dr. Alexander M. Lin, MD |
|
|
Dr. Min R. Cheung, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jay F. Dorsey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edgar Ben-Josef, MD |
|
|
Dr. Michelle Alonso-Basanta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary R. Peters, MD |
|
|
Dr. David R. Grossman, MD |
|
|
Dr. Lisa B. Johnson, MD
This Doctor is OpenDoctor Recommended.
|